Predict & Prevent vital emergencies
in a hospital environment
PREVIA MEDICAL develops digital biomarkers capable of analyzing the data of thousands of patients in real time, identifying at-risk patients, and immediately alerting medical staff.
The PREVIA © Platform
An easy-to-use and ergonomic interface designed for healthcare professionals.
Continuous Monitoring
All patients across all departments benefit from 24/7 continuous monitoring through the analysis of their data: vital signs, laboratory results, and medical history.
Data Analysis
The collected data is analyzed in real-time using predictive models. These models can identify abnormal patterns or trends that might indicate an imminent risk of a life-threatening emergency.
Early Alert Detection
When early signs of a life-threatening emergency are detected, the system automatically generates an alert that is sent to the relevant healthcare professionals.
Swift Intervention
The alert enables medical staff to take immediate action to prevent or address the life-threatening emergency.
Digital Biomarkers
Our system, powered by advanced artificial intelligence, utilizes digital biomarkers to anticipate the risks of medical complications. This approach enables medical staff to proactively intervene by accurately forecasting potential risks.
These biomarkers can detect subtle variations in clinical parameters that might remain unnoticed using conventional methods.
Our technology marks a significant advancement in predictive medicine, enhancing patient health monitoring and proactive management.
SEPSI Score ©
AKI Score ©
ARDS Score ©
ACR Score ©
The Benefits
Doctors
Early Identification
of At-Risk Patients
Optimizing
Care Pathways
Hospitals
Cost reduction
Improving care performance
Patients
Reduced
mortality rate
Improved
quality of life
PREVIA MEDICAL places data security at the heart of its activity.
Confidentiality
Patient data is stored securely and confidentially on a healthcare data hosting service. Information is accessible only to authorized personnel in accordance with the General Data Protection Regulation N° 2016/679.
Availability
The solution is available at all times for authorized users. Downtimes are monitored, limited, and efficiently managed in case of any issues.
Traceability
All activity regarding the data is recorded and traceable, ensuring transparency and accountability in managing and utilizing sensitive information.
Authentication
Users are securely authenticated before accessing data. Passwords are complex and regularly updated.
News
📢 Grant announcement
October 2024,
PREVIA MEDICAL secures €1.1 million grant to fund R&D 🔬of an innovation that takes care of your kidneys ...
Today, we are pleased to unveil a new milestone in our development: the creation of a new prediction score for acute renal failure, a new indication that strengthens our ability to predict and prevent life-threatening emergencies.
Why is this important?
Acute renal failure affects millions of patients every year. Thanks to our technology, by analysing patient data in real time, we will be able to detect it more quickly and intervene at an early stage, thereby offering a better chance of survival and reducing after-effects.
Funding and collaboration: We are also delighted to announce that this project has received €1.1m in funding, in collaboration with world-renowned academic institutions. This support will enable us to develop the team, consolidate our platform and deploy our technology in new hospital centres to demonstrate the benefits of this major breakthrough.
A huge thank you to our dedicated team and our partners for their ongoing commitment to this adventure! Together, we are shaping the future of predictive medicine.
Referencing on the LOGIMED market
September 2024,
1 465 UniHA member hospitals can now order the SEPSI Score.
The LOGIMED market for medical software includes more than 135 publishers and 280 solutions in 18 functional areas.
Our innovative SEPSI Score solution, which specialises in the detection of sepsis, has been singled out in the ‘medical decision support’ category.
As a winner in the pharmacy and biology category of the FHF Research & Innovation Fund, PREVIA MEDICAL benefits from special support from UniHA to help us grow, particularly in the area of purchasing.
We are proud to see our solutions for detecting and preventing life-threatening emergencies recognised and supported by major purchasing groups.
📌 Find PREVIA MEDICAL in the UniHA catalogue
SFAR Congress
September 2024,
🚨 We are delighted to announce that PREVIA MEDICAL is a partner of the SFAR - Société française d'anesthésie et de réanimation 2024 congress! 🚨
📅 Meet our team from 18 to 20 September at the Palais des Congrès in Paris, stand S7.
🔬 We'll be presenting our SEPSI Score solution, which detects sepsis up to 48 hours before the first clinical signs appear!
We will also be sharing our latest developments and technological advances.
🤝 Come and see us, we'll be delighted to welcome you and talk to you.
Biotuesdays
September 2024,
Invitation to the BIOTUESDAYS organised by the Lyon metropolitan area and presentation of PREVIA MEDICAL at this event highlighting 💡 companies in the Lyon ecosystem.
We were able to present our innovative solution for preventing life-threatening emergencies in hospitals.
A big thank you to the Metropole of Lyon for this invitation, as well as to all the players present for these enriching exchanges at the heart of our dynamic ecosystem.
HIMSS 2024
Rome, May 2024
PREVIA MEDICAL to participate in HIMSS 2024 🇮🇹
We were alongside the delegation from the AURA region with HCL, Galeon, Le Vinatier.
Great meetings, and relevant conferences on prevention and AI in hospital health.
SANTEXPO & VIVATECH
Paris, May 2024
We are delighted to announce our victories, symbolizing our commitment to health innovation, with two trophies:
Innovation Trophy from the FHF Research & Innovation Fund, in the Pharmacy and Biology category.
La Poste Group Health Trophy 2024, Winner in the Health category.
Great collaborations in perspective with the FHF Fund and La Poste Groupe Santé.
AURA & Geneva Economic Meetings
Geneva, May 16, 2024
PREVIA MEDICAL was invited to participate in the AURA and Geneva Economic Meetings on the theme: AI in Health: Innovations and Perspectives in AURA and in Geneva, which took place at the Biotech Campus in Geneva.
Quentin FRANCOIS positioned himself as an expert during the round table entitled: “How can innovative companies in AI applied to biotechs, medtechs and pharma collaborate with health establishments?”
MEDI'NOV CONNECTION 2024
3 April 2024, Lyon
Quentin FRANCOIS took part in the round table "AI in healthcare - uses, prospects and regulations for more effective medicine for the benefit of patients" as part of the Médi'Nov Connection conference.
Many debates around technological, clinical and regulatory challenges.
Masterclass SEPSIS
14 & 15 March 2024, Marseille
The entire PREVIA MEDICAL team is proud to have been a partner of the SEPSIS MASTERCLASS.
Congratulations to Dr. Nicolas Kader ETTAHAR, Head of the Infectious and Tropical Diseases Department at Valenciennes Hospital, for his presentation on "Predict and prevent the life-threatening emergencies using digital biomarkers: an illustration of the reuse of health data in the prevention of sepsis".
CHU Healthtech Connexion Day
20 November 2023, Marseille
We had the opportunity to present our PREVIA © platform, which helps predict and prevent life-threatening emergencies 🚨 in the hospital environment 🏥 and to outline its medico-economic benefits alongside AP HP, CHU de Lille, CHU de Toulouse, Owkin and the Ospi group.
HealthTech For Care Innovation Award
24 & 25 October 2023, Paris
PREVIA MEDICAL is one of the winners of the 2023 HealthTech For Care award, proudly representing France 🇫🇷 in this international community! 🏆 We pitched among 22 impressive global HealthTech companies, and I'm pleased to say that PREVIA has been awarded the silver medal.
World Sepsis Awareness Day 🦠
13 September 2023, Lyon
The PREVIA MEDICAL team will be taking part in the regional health conference, alongside a number of innovators. The event brings together providers of innovative solutions in the healthcare sector.
PREVIA MEDICAL has been selected to be part of the prestigious 🇺🇸 U.S Market Gateway Accelerator for #Medtech program.
During our week in Philadelphia, we had the opportunity to meet investors and hospitals.
🎯 The primary aim of this program is to plan the roadmap, timing, and budget for PREVIA’s entry into the US #Market.
Michel Denisot interviewed Quentin François, President of PREVIA MEDICAL, in LE GRAND ENTRETIEN.
During this interview, we presented our digital biomarker SEPSI Score ©.
Frequently Asked Questions
PREVIA © is a computer-based solution for preventing life-threatening emergencies in hospital settings. It enables healthcare professionals to quickly detect any deterioration in a patient's health status and take preventive measures to avoid potential life-threatening situations.
PREVIA © is designed for healthcare professionals working in hospitals. The solution is designed to help healthcare professionals monitor patients' state of health and rapidly detect any deterioration. It can be used in all hospital departments where monitoring vital emergencies is essential to patient care.
Connected to the medical record and other hospital data sources, the PREVIA © solution analyzes data in real-time and utilizes digital biomarkers to determine if they fall within normal limits or indicate a risk of a life-threatening emergency. If a risk is detected, an alert is sent to the healthcare professionals responsible for the patients.
A digital biomarker is an objective measure of a patient's health status derived from data collected through digital tools. PREVIA MEDICAL offers unique biomarkers created from hundreds of parameters like physiological data, laboratory results, and medical history. Digital biomarkers are used to non-invasively monitor patients' health status and quickly detect any deterioration.
Patient data is stored securely and confidentially on a health data host. Information is accessible only to authorized persons in accordance with General Data Protection Regulation N° 2016/679. Data is encrypted to guarantee confidentiality and integrity.
Information is accessible only to authorized persons in accordance with General Data Protection Regulation N° 2016/679. Healthcare professionals in charge of the patient have access to the data required to monitor the patient's state of health.
Solution downtime is continuously monitored to guarantee availability when needed. Preventive measures are put in place to avoid unplanned downtime. In the event of a problem, a technical support team is on hand to intervene quickly and solve the problem.
The security of patient data is an absolute priority for PREVIA MEDICAL. Users are securely authenticated before accessing data. Passwords are complex and regularly updated to guarantee their security. Data access is limited and controlled to prevent unauthorized access.
PREVIA © monitors laboratory results, medication, medical history and vital signs (blood pressure, heart rate, respiratory rate, body temperature, oxygen saturation). These data are essential for monitoring a patient's state of health and detecting any deterioration at an early stage.
An alert is automatically triggered when the patient's vital signs exceed a pre-defined threshold. The solution analyzes the patient's vital signs data in real time, and determines whether they are within normal limits or indicate a risk of life-threatening emergency. If a risk is detected, an alert is sent to the healthcare professionals in charge of the patient.
Let's Build Your Project Together
Discover Our Predictive Medicine Solution
Our team is at your disposal to present our services.